Caseware UK (AP4) 2023.0.135 2023.0.135 82023-05-01false9truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 06676109 2023-05-01 2024-04-30 06676109 2022-05-01 2023-04-30 06676109 2024-04-30 06676109 2023-04-30 06676109 c:Director3 2023-05-01 2024-04-30 06676109 c:Director4 2023-05-01 2024-04-30 06676109 d:PlantMachinery 2023-05-01 2024-04-30 06676109 d:PlantMachinery 2024-04-30 06676109 d:PlantMachinery 2023-04-30 06676109 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 06676109 d:FurnitureFittings 2023-05-01 2024-04-30 06676109 d:FurnitureFittings 2024-04-30 06676109 d:FurnitureFittings 2023-04-30 06676109 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 06676109 d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 06676109 d:Goodwill 2024-04-30 06676109 d:Goodwill 2023-04-30 06676109 d:CurrentFinancialInstruments 2024-04-30 06676109 d:CurrentFinancialInstruments 2023-04-30 06676109 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 06676109 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 06676109 d:ShareCapital 2024-04-30 06676109 d:ShareCapital 2023-04-30 06676109 d:RetainedEarningsAccumulatedLosses 2024-04-30 06676109 d:RetainedEarningsAccumulatedLosses 2023-04-30 06676109 c:FRS102 2023-05-01 2024-04-30 06676109 c:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 06676109 c:FullAccounts 2023-05-01 2024-04-30 06676109 c:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 06676109 e:PoundSterling 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure
Registered number: 06676109













Castle View Surgery Limited

Financial statements
Information for filing with the registrar

30 April 2024




 
Castle View Surgery Limited


Balance sheet
At 30 April 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 6 
75,528
79,954

  
75,528
79,954

Current assets
  

Stocks
  
13,351
17,085

Debtors
 7 
153,025
137,034

Cash at bank and in hand
  
144,845
157,356

  
311,221
311,475

Creditors: amounts falling due within one year
 8 
(68,131)
(58,098)

Net current assets
  
 
 
243,090
 
 
253,377

Total assets less current liabilities
  
318,618
333,331

Provisions for liabilities
  

Deferred tax
  
(17,936)
(19,132)

Net assets
  
300,682
314,199


Capital and reserves
  

Called up share capital 
  
400
400

Profit and loss account
  
300,282
313,799

Shareholders' funds
  
300,682
314,199


1

 
Castle View Surgery Limited

    
Balance sheet (continued)
At 30 April 2024

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 9 January 2025.




Dr N Gandhi
Dr S Vasireddy
Director
Director

Registered number: 06676109
The notes on pages 3 to 8 form part of these financial statements. 

2

 
Castle View Surgery Limited
 
 

Notes to the financial statements
Year ended 30 April 2024

1.


General information

Castle View Surgery Limited ('the company') is a private company limited by shares, incorporated and domiciled in the United Kingdom and registered in England and Wales. The address of the registered office is 70 North Road, Durham, DH1 4SQ.


2.


Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3.Accounting policies

 
3.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 
3.2

Revenue

The turnover shown in the profit and loss account represents private fees and capitation schemes income receivable during the period.

 
3.3

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3

 
Castle View Surgery Limited
 

 
Notes to the financial statements
Year ended 30 April 2024

3.Accounting policies (continued)

 
3.4

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
3.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Plant and machinery
-
10%
reducing balance
Fixtures and fittings
-
20%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
3.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
3.7

Financial instruments

The company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements,
4

 
Castle View Surgery Limited
 

 
Notes to the financial statements
Year ended 30 April 2024

3.Accounting policies (continued)


3.7
Financial instruments (continued)

when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

 
3.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

5

 
Castle View Surgery Limited
 
 

Notes to the financial statements
Year ended 30 April 2024

4.


Employees

The average monthly number of employees, including directors, during the year was 8 (2023 - 9).


5.


Intangible assets




Goodwill

£



Cost


At 1 May 2023
445,000



At 30 April 2024

445,000



Amortisation


At 1 May 2023
445,000



At 30 April 2024

445,000



Net book value



At 30 April 2024
-



At 30 April 2023
-



6

 
Castle View Surgery Limited
 
 

Notes to the financial statements
Year ended 30 April 2024

6.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Total

£
£
£



Cost or valuation


At 1 May 2023
181,364
869
182,233


Additions
306
3,548
3,854



At 30 April 2024

181,670
4,417
186,087



Depreciation


At 1 May 2023
102,030
249
102,279


Charge for the year
7,951
329
8,280



At 30 April 2024

109,981
578
110,559



Net book value



At 30 April 2024
71,689
3,839
75,528



At 30 April 2023
79,334
620
79,954


7.


Debtors

2024
2023
£
£


Trade debtors
46,981
41,228

Other debtors
104,001
93,622

Prepayments and accrued income
2,043
2,184

153,025
137,034


7

 
Castle View Surgery Limited
 
 

Notes to the financial statements
Year ended 30 April 2024

8.


Creditors: amounts falling due within one year

2024
2023
£
£

Trade creditors
7,311
9,981

Corporation tax
52,755
40,842

Other taxation and social security
1,201
877

Accruals and deferred income
6,864
6,398

68,131
58,098


 
8